| |
| |
|
| Insider
Information: |
Aselage Steve |
| Relationship: |
Director |
| City: |
Fremont |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
293,421 |
|
|
Indirect Shares
|
19,500 |
|
|
| Direct
Value |
$6,843,889 |
|
|
|
Indirect Value
|
$130,455 |
|
|
| Total
Shares |
312,921 |
|
|
| Total
Value |
$6,974,344 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
4
|
5
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
4
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
-4.0
|
1.5
|
| Percentage
Gain/Loss : |
 -31.1%
|
 62.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cti Biopharma Corporation |
CTIC |
EVP, Global Commercial... |
2005-06-30 |
24,133 |
2004-08-03 |
0 |
Premium* |
|
|
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Business Of... |
2012-07-02 |
59,030 |
2006-04-28 |
0 |
Premium* |
|
|
Travere Therapeutics, Inc |
TVTX |
Director |
2022-05-11 |
146,919 |
2021-11-05 |
19,500 |
Premium* |
|
|
Acer Therapeutics Inc |
ACER |
Director |
2023-11-17 |
0 |
2017-09-19 |
0 |
Premium* |
|
|
Biocryst Pharmaceuticals Inc |
BCRX |
Director |
2023-06-13 |
63,339 |
2019-03-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
169 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Ops |
• – – |
2006-11-29 |
4 |
S |
$17.23 |
$86,150 |
D/D |
(5,000) |
2,829 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Dev |
• – – |
2007-10-01 |
4 |
AS |
$24.90 |
$125,471 |
D/D |
(5,000) |
4,895 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Dev |
• – – |
2007-10-01 |
4 |
OE |
$7.16 |
$35,800 |
D/D |
5,000 |
9,895 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Dev |
• – – |
2008-01-02 |
4 |
OE |
$7.16 |
$35,800 |
D/D |
5,000 |
12,034 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Dev |
• – – |
2008-01-02 |
4 |
AS |
$35.28 |
$180,398 |
D/D |
(5,000) |
7,034 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
• – – |
2010-03-04 |
4 |
S |
$21.50 |
$107,500 |
D/D |
(5,000) |
50,361 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • – |
2016-11-21 |
4 |
S |
$21.00 |
$105,000 |
D/D |
(5,000) |
243,756 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • – |
2017-06-14 |
4 |
S |
$17.85 |
$89,250 |
D/D |
(5,000) |
245,556 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • – |
2017-12-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
240,556 |
0 |
- |
|
| ACER |
Acer Therapeutics Inc |
Director |
– • – |
2019-07-03 |
4 |
B |
$3.72 |
$18,581 |
D/D |
5,000 |
18,905 |
2.39 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Director |
– • – |
2021-11-01 |
4 |
AS |
$29.48 |
$147,400 |
I/I |
(5,000) |
23,000 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
Director |
– • – |
2020-12-15 |
4 |
S |
$26.02 |
$144,385 |
D/D |
(5,549) |
196,667 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • – |
2018-11-14 |
4 |
AS |
$23.63 |
$131,735 |
D/D |
(5,550) |
258,833 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • – |
2018-11-15 |
4 |
AS |
$24.21 |
$134,969 |
D/D |
(5,550) |
253,283 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Global Commercial Ops |
• – – |
2004-02-18 |
4 |
B |
$8.90 |
$54,000 |
D/D |
6,000 |
6,000 |
2.74 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • – |
2018-12-20 |
4 |
AS |
$21.97 |
$135,958 |
D/D |
(6,188) |
265,960 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • – |
2018-12-21 |
4 |
AS |
$21.69 |
$134,829 |
D/D |
(6,188) |
259,772 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
• – – |
2010-03-05 |
4 |
S |
$21.95 |
$140,831 |
D/D |
(6,416) |
43,945 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Director |
– • – |
2020-12-02 |
4 |
S |
$23.43 |
$184,849 |
D/D |
(7,891) |
202,216 |
0 |
% |
|
| ACER |
Acer Therapeutics Inc |
Director |
– • – |
2021-12-10 |
4 |
B |
$2.04 |
$16,287 |
D/D |
7,984 |
73,905 |
2.39 |
% |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
• – – |
2010-11-17 |
4 |
S |
$25.75 |
$206,000 |
D/D |
(8,000) |
29,881 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • – |
2014-11-21 |
4 |
B |
$8.50 |
$73,950 |
D/D |
8,700 |
371,756 |
2.81 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
• – – |
2011-05-25 |
4 |
S |
$27.00 |
$247,779 |
D/D |
(9,177) |
43,978 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
• – – |
2011-05-25 |
4 |
OE |
$17.33 |
$159,037 |
D/D |
9,177 |
53,155 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Global Commercial Ops |
• – – |
2004-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
16,000 |
|
- |
|
169 Records found
|
|
Page 4 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
